[O-aminoazotoluene inhibits DENA-induced hepatocarcinogenesis when used together in mice].
When used separately, diethylnitrosamine (DENA) initiates 4-6 times more neoplastic lesions in the liver of suckling mice than ortho-aminoazotoluene (OAT) lower. However, after combined treatment with either carcinogen the total number of hepatic lesions was significantly than that in mice injected with DENA only. Similar inhibition of DENA-induced hepatocarcinogenesis was observed when OAT was administered 8-12 hrs after DENA. Our findings cannot be adequately explained except by competition of the carcinogens for supposedly target molecules of protein origin, presumably, transcription factors, which contribute to generation of genetic information. They have different affinities for different compounds and, therefore, suffer different damage from the latter functioning.
Kaledin
V I
VI
Il'nitskaia
S I
SI
Baginskaia
N V
NV
D000818:Animals; D016588:Anticarcinogenic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D002273:Carcinogens / Q000037:antagonists & inhibitors*; D004052:Diethylnitrosamine / Q000037:antagonists & inhibitors*; D004334:Drug Administration Schedule; D008114:Liver Neoplasms, Experimental / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control*; D008175:Lung Neoplasms / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control*; D008297:Male; D051379:Mice; D008808:Mice, Inbred CBA; D008813:Mice, Inbred ICR; D009374:Neoplasms, Experimental / Q000517:prevention & control; D013997:Time Factors; D009762:o-Aminoazotoluene / Q000008:administration & dosage / Q000494:pharmacology*
D016588:Anticarcinogenic Agents; D002273:Carcinogens; D004052:Diethylnitrosamine; D009762:o-Aminoazotoluene